Chen Ke-Lin, Bi Kai-Shun, Han Fei, Zhu He-Yun, Zhang Xiao-Shu, Mao Xin-Juan, Yin Ran
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China; School of Pharmacy, Jilin Medical College, Jilin 132013, China.
J Ethnopharmacol. 2015 Aug 22;172:402-9. doi: 10.1016/j.jep.2015.06.043. Epub 2015 Jul 7.
Zhi-Zi-Da-Huang decoction (ZZDHD), a classic traditional Chinese medicine (TCM) formula composed of four herbal medicines, has been widely used to treat various hepatobiliary disorders for a long time in China. However, the pharmacological effect of ZZDHD on liver injury with cholestasis is unrevealed.
To investigate the hepatoprotective effect of ZZDHD against α-naphthylisothiocyanate (ANIT)-induced liver injury with cholestasis in rats.
The rats were intragastrically (i.g.) given ZZDHD at doses of 1, 2 and 4 g/kg (crude drug/body weight) once a day for seven days and treated with ANIT (75 mg/kg via i.g.) to cause liver injury at 12h after the fifth administration. The serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltranspeptidase (γ-GTP), total bilirubin (TBIL), direct bilirubin (DBIL) and total bile acid (TBA), as well as bile flow were measured at 48 h after ANIT treatment to evaluate the protective effect of ZZDHD. Moreover, the possible protective mechanisms were elucidated by assays of liver enzyme activities and component contents including malondialdehyde (MDA), myeloperoxidase (MPO), lipid peroxide (LPO), superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT). The biochemical observations were supplemented by histopathological examination. Ultra fast liquid chromatography-mass spectrometry (UFLC-MS) was used for the phytochemical analysis of ZZDHD.
The high dose (4 g/kg) and middle dose (2g/kg) of ZZDHD exhibited significant and dose-dependent protective effect on ANIT-induced liver injury with cholestasis by reversing the changes in bile flow, the serum and hepatic enzymes, and histopathology of the liver tissue. Meanwhile, it was found that the low dose (1g/kg) of ZZDHD did not improve the biochemical indexes except serum TBIL, DBIL and TBA, which showed little protective effect. Phytochemical analysis revealed the presence of sixteen compounds in ZZDHD.
This study indicates that ZZDHD exerted a hepatoprotective effect on ANIT-induced liver injury with cholestasis in rats, and the mechanism of this activity is possibly related to its antioxidant properties.
栀子大黄汤(ZZDHD)是一种由四味草药组成的经典中药方剂,在中国长期广泛用于治疗各种肝胆疾病。然而,ZZDHD对胆汁淤积性肝损伤的药理作用尚未阐明。
探讨ZZDHD对α-萘异硫氰酸酯(ANIT)诱导的大鼠胆汁淤积性肝损伤的保肝作用。
大鼠每天一次灌胃给予剂量为1、2和4 g/kg(生药/体重)的ZZDHD,连续7天,并在第5次给药后12小时用ANIT(75 mg/kg灌胃)诱导肝损伤。在ANIT处理后48小时测量血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、γ-谷氨酰转肽酶(γ-GTP)、总胆红素(TBIL)、直接胆红素(DBIL)和总胆汁酸(TBA)水平以及胆汁流量,以评估ZZDHD的保护作用。此外,通过测定肝酶活性和成分含量,包括丙二醛(MDA)、髓过氧化物酶(MPO)、脂质过氧化物(LPO)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)和过氧化氢酶(CAT),阐明可能的保护机制。通过组织病理学检查补充生化观察结果。采用超快速液相色谱-质谱联用(UFLC-MS)对ZZDHD进行植物化学分析。
ZZDHD高剂量(4 g/kg)和中剂量(2 g/kg)通过逆转胆汁流量、血清和肝酶以及肝组织病理学变化,对ANIT诱导的胆汁淤积性肝损伤表现出显著的剂量依赖性保护作用。同时发现,ZZDHD低剂量(1 g/kg)除血清TBIL、DBIL和TBA外,未改善生化指标,保护作用较弱。植物化学分析显示ZZDHD中存在16种化合物。
本研究表明,ZZDHD对ANIT诱导的大鼠胆汁淤积性肝损伤具有保肝作用,其作用机制可能与其抗氧化特性有关。